The landscape of malignancy treatment is constantly evolving, with a growing emphasis on identifying novel therapeutic targets for drug creation. Traditional therapies often attack rapidly dividing cells, leading to significant side effects. However, the emergence of sophisticated genomic profiling techniques has transformed our understanding of tu